Every product sourced exclusively from FDA-registered 503A compounding pharmacies using pharmaceutical-grade active pharmaceutical ingredients. Only what is currently legal to compound — updated in real time.
Every compound sourced exclusively from FDA-registered 503A pharmacies. Only what is currently legal to compound — updated in real time as regulations change.
Every partner pharmacy holds active FDA registration and state-specific compounding licenses. No grey-market sourcing, ever.
Certificate of Analysis accompanies every shipment — potency, purity, sterility, and endotoxin testing verified before release.
Formulary updates automatically when FDA bulk substance classifications change — your practice stays compliant and current.
A glucagon-like peptide-1 receptor agonist indicated for chronic weight management. Mimics the incretin hormone GLP-1 to regulate appetite, slow gastric emptying, and support sustained weight loss in conjunction with lifestyle modification.
Route: Subcutaneous Injection
A dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist offering enhanced metabolic response. Targets two incretin pathways simultaneously for superior weight management and glycemic outcomes compared to single-agonist therapies.
Route: Subcutaneous Injection
A critical coenzyme present in every cell, essential for cellular energy production, DNA repair, and mitochondrial function. Supports anti-aging pathways, cognitive clarity, and metabolic health through direct cofactor replenishment.
Route: IV Infusion or Subcutaneous
The body's most powerful endogenous antioxidant, delivered intravenously for maximum bioavailability. Supports detoxification pathways, reduces oxidative stress, brightens skin, and enhances liver function and immune resilience.
Route: IV Push
The bioactive, methylated form of vitamin B12 essential for neurological function, red blood cell formation, and energy metabolism. Superior to cyanocobalamin for direct cellular utilization without requiring hepatic conversion.
Route: IM Injection
A growth hormone releasing hormone analog that stimulates the pituitary gland to produce and secrete growth hormone naturally. Supports anti-aging, improved body composition, deeper sleep quality, and accelerated tissue recovery.
Route: Subcutaneous Injection
A synergistic peptide combination — Ipamorelin as a selective GH secretagogue with CJC-1295 as a GHRH analog. Currently in regulatory gray area — CJC-1295 availability subject to FDA classification changes.
Status: Regulatory Review
A melanocortin receptor agonist that acts on the central nervous system to support sexual wellness. Works through neurological pathways rather than vascular mechanisms, offering a distinct approach for both male and female patients.
Route: Subcutaneous Injection
A naturally occurring thymic peptide that modulates and enhances immune system function. Supports T-cell maturation, dendritic cell activity, and balanced immune response — used clinically for immune support and resilience optimization.
Route: Subcutaneous Injection
A neuropeptide involved in the regulation of sleep architecture, specifically promoting delta wave (deep) sleep. Supports circadian rhythm normalization, stress reduction, and restorative sleep quality without sedative dependency.
Route: Subcutaneous Injection
A combination of methionine, inositol, choline, and B-vitamins designed to support fat metabolism and liver function. Enhances the body's ability to metabolize lipids, supports energy levels, and complements weight management protocols.
Route: IM Injection
The following compounds are currently classified as FDA Category 2 bulk drug substances and are not available for compounding at this time. We continue to monitor regulatory developments and will update availability if classifications change.
A synthetic peptide derived from gastric juice proteins, previously used for tissue repair and gastrointestinal support. Currently classified as FDA Category 2 — not available for 503A compounding.
Status: Unavailable — FDA Category 2
A naturally occurring peptide involved in tissue repair, cell migration, and angiogenesis. Currently classified as FDA Category 2 — not available for 503A compounding.
Status: Unavailable — FDA Category 2
Our formulary is dynamic — not static. Compound availability is updated in real time as FDA bulk substance classifications change. When a product is added or removed, every Ventra member is notified immediately with updated guidance, compliance documentation, and alternative recommendations.
Ventra's compliance team actively monitors the FDA, state pharmacy boards, and the National Association of Boards of Pharmacy (NABP) to ensure that every compound we offer meets current federal and state regulations. Your practice stays compliant — we handle the regulatory complexity.
Join Ventra Wellness to access our full formulary at GPO-negotiated pricing — with pharmacy sourcing, compliance support, and clinical protocols included.